<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Artificial Intelligence | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/artificial-intelligence/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Wed, 22 Jul 2026 12:13:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Artificial Intelligence | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform</title>
		<link>https://tissuepathology.com/2026/07/22/techcyte-marks-11-million-ai-assisted-scans-across-its-global-platform/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 22 Jul 2026 12:13:49 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[platform]]></category>
		<category><![CDATA[Techcyte]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24566</guid>

					<description><![CDATA[<p>OREM, UT, UNITED STATES, July 21, 2026 /EINPresswire.com/ &#8212; Techcyte, a worldwide leader in AI-powered digital pathology and diagnostics, today announced it has surpassed 11 million AI-assisted scans processed across active customer environments spanning human, veterinary, and environmental diagnostic platforms. The milestone marks a significant step in the company&#8217;s mission to make AI-driven diagnostics accessible to [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/22/techcyte-marks-11-million-ai-assisted-scans-across-its-global-platform/">Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule</title>
		<link>https://tissuepathology.com/2026/07/21/optiscan-imaging-advances-head-and-neck-cancer-study-ahead-of-schedule/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 21 Jul 2026 11:30:50 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[head cancer]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[live imaging]]></category>
		<category><![CDATA[neck cancer]]></category>
		<category><![CDATA[Optiscan]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24564</guid>

					<description><![CDATA[<p>Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions. Optiscan Imaging (ASX: OIL) has begun Stage 2 of its first-in-human head and neck cancer imaging study at St John of God Murdoch Hospital in Perth ahead of schedule. The hospital’s Human Research Ethics [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/21/optiscan-imaging-advances-head-and-neck-cancer-study-ahead-of-schedule/">Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: How We Built Intelligence into the Pathology Platform</title>
		<link>https://tissuepathology.com/2026/07/20/proscia-how-we-built-intelligence-into-the-pathology-platform/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 20 Jul 2026 13:24:44 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Concentriq]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[Software]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24561</guid>

					<description><![CDATA[<p>The latest from the Proscia blog: This post is about Concentriq AP and Concentriq LS, which are for Research Use Only, and the research and laboratory workflows they support. It does not describe diagnostic use. Concentriq AP-Dx, Proscia&#8217;s product cleared for primary diagnosis, is a separate product and is not covered here. We recently announced [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/20/proscia-how-we-built-intelligence-into-the-pathology-platform/">Proscia: How We Built Intelligence into the Pathology Platform</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Techcyte Fusion® Anatomic Pathology advances digital pathology transformation at Mayo Clinic</title>
		<link>https://tissuepathology.com/2026/07/17/techcyte-fusion-anatomic-pathology-advances-digital-pathology-transformation-at-mayo-clinic/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 17 Jul 2026 11:38:08 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[anatomic pathology]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Mayo Clinic]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Techcyte]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24559</guid>

					<description><![CDATA[<p>Techcyte and Mayo Clinic: Deployment across Mayo Clinic pathology practices integrates AI-enabled digital pathology with historical pathology images and clinical data in a unified workflow. Mayo Clinic and Techcyte today announced the implementation of Anatomic Pathology (AP) technology, a next-generation digital pathology platform developed through a co-development and intellectual property licensing agreement between the two [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/17/techcyte-fusion-anatomic-pathology-advances-digital-pathology-transformation-at-mayo-clinic/">Techcyte Fusion® Anatomic Pathology advances digital pathology transformation at Mayo Clinic</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Leica Biosystems to Acquire StatLab</title>
		<link>https://tissuepathology.com/2026/07/16/leica-biosystems-to-acquire-statlab/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 16 Jul 2026 12:12:59 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Danaher]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[leica biosystems]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[StatLab]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24556</guid>

					<description><![CDATA[<p>DEER PARK, Ill. – July 14, 2026 – Leica Biosystems, an operating company of Danaher (the “Company”), and a global leader in anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has entered into a definitive agreement to acquire privately held StatLab Medical Products (“StatLab”), a leading global developer and manufacturer of [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/16/leica-biosystems-to-acquire-statlab/">Leica Biosystems to Acquire StatLab</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Indica Labs: HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability</title>
		<link>https://tissuepathology.com/2026/07/15/indica-labs-halo-ap-2-5-advances-digital-pathology-with-enhanced-automation-collaboration-and-scalability/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 15 Jul 2026 12:28:27 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Indica Labs: HALO AP 2.5]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Software]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24553</guid>

					<description><![CDATA[<p>Albuquerque, NM, July 14th, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced a new software release designed to streamline and scale digital pathology workflows through enhanced automation, collaboration, and system transparency. “Clinical laboratories need digital pathology systems that can adapt to the way their teams actually work,” said Hallie [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/15/indica-labs-halo-ap-2-5-advances-digital-pathology-with-enhanced-automation-collaboration-and-scalability/">Indica Labs: HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
